CH / CHIP Working Group
Co-Chairs
Duane Hassane, PhD
Senior Director, Head of Translational Omics, Hematology R&D
AstraZeneca
Robert Tell, PhD
SVP, Bioinformatics
Tempus Labs, Inc.
Current Projects
Developing paper on describing considerations and best practices for scientists interrogating the output of diagnostic tests and attempting to disambiguate CH from biomarkers of interest in liquid biopsy testing.
Participating Organizations
Association for Molecular Pathology (AMP), AstraZeneca, Delfi Diagnostics, Exact Sciences, Guardant Health, International Society of Liquid Biopsy (ISLB), Johnson & Johnson, LGC SeraCare, Natera, Tempus, University of Arkansas for Medical Sciences (UAMS)
Meetings
This working group meets on zoom every other Thursday from 12:00 - 1:00 PM EST.
Special workshops and sessions:
Not applicable at this time.